Corient Private Wealth
VIR icon

Corient Private Wealth’s Vir Biotechnology VIR Stock Holding History

Corient Private Wealth’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.63M Sell
293,688
-229,225
-44% -$1.83M ﹤0.01% 1118
2025
Q4 		$3.14M Buy
522,913
+263,217
+101% +$1.57M ﹤0.01% 1279
2025
Q3 		$1.48M Buy
259,696
+354
+0.1% +$1.81K ﹤0.01% 1220
2025
Q2 		$1.31M Buy
259,342
+966
+0.4% +$5.18K ﹤0.01% 1235
2025
Q1 		$1.67M Buy
258,376
+856
+0.3% +$7.61K ﹤0.01% 1042
2024
Q4 		$1.89M Sell
257,520
-25,545
-9% -$201K ﹤0.01% 1029
2024
Q3 		$2.12M Buy
283,065
+16,968
+6% +$147K ﹤0.01% 1067
2024
Q2 		$2.37M Sell
266,097
-3,815
-1% -$36.6K ﹤0.01% 958
2024
Q1 		$2.73M Buy
269,912
+2,633
+1% +$26.8K ﹤0.01% 888
2023
Q4 		$2.69M Buy
267,279
+27,115
+11% +$248K ﹤0.01% 881
2023
Q3 		$2.25M Sell
240,164
-838
-0.3% -$12K 0.01% 866
2023
Q2 		$5.91M Buy
241,002
+167
+0.1% +$4.19K 0.01% 584
2023
Q1 		$5.6M Buy
+240,835
New +$6.16M 0.02% 558

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return